AI drug discovery draws investor bets

Investors continue funding AI drug discovery startups despite a lack of approved drugs from the approach. The gap between AI-driven development and regulatory approval has not deterred venture capital. Companies like Recursion Pharmaceuticals and Insilico Medicine have raised significant rounds.